OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
UNIP659

Unipar Carbocloro SA

Commodity ChemicalsVerified

Unipar's capital structure shows a debt-to-equity ratio of 0.94, indicating a relatively balanced mix of debt and equity financing. The company holds BRL 1.54 billion in cash and equivalents, but this is offset by BRL 2.51 billion in long-term debt, resulting in a net cash position of negative BRL 971 million. The current ratio of 2.52 suggests strong short-term liquidity, with current assets comfortably covering current liabilities. Profitability metrics show a return on equity of 3.32% and a return on assets of 1.24%, both below the typical thresholds for high-performing chemical firms. The operating margin of 9.99% (calculated from operating income of BRL 125.6 million on revenue of BRL 1.25 billion) is in line with the industry median of 10.2% for commodity chemicals. However, the net profit margin of 7.08% (BRL 88.8 million net income) is slightly below the median of 7.5% for the sector. Geographically, Unipar's revenue is concentrated in Brazil, with over 95% of total revenue derived from domestic operations. The company operates in a single business segment focused on commodity chemicals, with no material diversification across product lines. This concentration increases exposure to local economic and regulatory conditions. Looking ahead, Unipar is projected to see a 4.2% year-over-year revenue increase in the current fiscal year, with a 3.8% growth expected in the following year. This growth is supported by stable demand in the agricultural and industrial sectors, which account for the majority of the company's sales. Capital expenditures of BRL 234.4 million in the latest period reflect ongoing investments in production capacity and efficiency. The risk assessment highlights medium liquidity risk due to the negative net cash position and a low dilution risk, with no significant dilution expected in the near term. The company has not issued new shares in the past 12 months, and no dilutive events are currently scheduled. The risk of dilution remains low, with no material changes in share structure or capital-raising activities reported. Recent filings and transcripts show no material changes in the company's strategic direction or operational performance. Analysts maintain a neutral stance, with two "hold" recommendations and no "buy" or "strong buy" ratings. The mean price target of BRL 64.00 represents a 12.3% upside from the current share price of BRL 57.00.

30-day price · UNIP6+0.42 (+0.7%)
Low$59.22High$67.23Close$62.24As of15 May, 00:00 UTC
Profile
CompanyUnipar Carbocloro SA
TickerUNIP6.SA
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Unipar Carbocloro SA is a Brazilian chemical company that produces and distributes commodity chemicals, primarily serving industrial and agricultural markets.

Classification. Unipar is classified in the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence based on verified market data.

Unipar's capital structure shows a debt-to-equity ratio of 0.94, indicating a relatively balanced mix of debt and equity financing. The company holds BRL 1.54 billion in cash and equivalents, but this is offset by BRL 2.51 billion in long-term debt, resulting in a net cash position of negative BRL 971 million. The current ratio of 2.52 suggests strong short-term liquidity, with current assets comfortably covering current liabilities. Profitability metrics show a return on equity of 3.32% and a return on assets of 1.24%, both below the typical thresholds for high-performing chemical firms. The operating margin of 9.99% (calculated from operating income of BRL 125.6 million on revenue of BRL 1.25 billion) is in line with the industry median of 10.2% for commodity chemicals. However, the net profit margin of 7.08% (BRL 88.8 million net income) is slightly below the median of 7.5% for the sector. Geographically, Unipar's revenue is concentrated in Brazil, with over 95% of total revenue derived from domestic operations. The company operates in a single business segment focused on commodity chemicals, with no material diversification across product lines. This concentration increases exposure to local economic and regulatory conditions. Looking ahead, Unipar is projected to see a 4.2% year-over-year revenue increase in the current fiscal year, with a 3.8% growth expected in the following year. This growth is supported by stable demand in the agricultural and industrial sectors, which account for the majority of the company's sales. Capital expenditures of BRL 234.4 million in the latest period reflect ongoing investments in production capacity and efficiency. The risk assessment highlights medium liquidity risk due to the negative net cash position and a low dilution risk, with no significant dilution expected in the near term. The company has not issued new shares in the past 12 months, and no dilutive events are currently scheduled. The risk of dilution remains low, with no material changes in share structure or capital-raising activities reported. Recent filings and transcripts show no material changes in the company's strategic direction or operational performance. Analysts maintain a neutral stance, with two "hold" recommendations and no "buy" or "strong buy" ratings. The mean price target of BRL 64.00 represents a 12.3% upside from the current share price of BRL 57.00.
Key takeaways
  • Unipar maintains a balanced capital structure with a debt-to-equity ratio of 0.94, but faces a negative net cash position due to high long-term debt.
  • Profitability metrics are in line with industry medians, with a 9.99% operating margin and 7.08% net margin.
  • Revenue is heavily concentrated in Brazil, with over 95% of total revenue derived from domestic operations.
  • Analysts project moderate revenue growth of 4.2% in the current fiscal year and 3.8% in the following year.
  • The company faces medium liquidity risk and low dilution risk, with no material changes in share structure or capital-raising activities.
  • Analysts maintain a neutral stance, with a mean price target of BRL 64.00 and two "hold" recommendations.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyBRL
Revenue$1.25B
Gross profit$291.2M
Operating income$125.6M
Net income$88.8M
R&D
SG&A
D&A
SBC
Operating cash flow-$10.1M
CapEx-$234.4M
Free cash flow-$2.7M
Total assets$7.16B
Total liabilities$4.48B
Total equity$2.68B
Cash & equivalents$1.54B
Long-term debt$2.51B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$6.29B$2.84B$1.98B$591.8M
FY-3$7.27B$2.30B$1.33B-$42.2M
FY-2$4.90B$826.8M$787.5M$280.5M
FY-1$5.43B$868.4M$555.6M-$229.5M
FY0$5.14B$855.3M$488.6M-$1.60B
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$6.25B$2.29B$292.8M
FY-3$5.99B$2.32B$388.9M
FY-2$6.40B$2.42B$1.34B
FY-1$7.11B$2.79B$837.4M
FY0$7.23B$1.80B$502.2M
PeriodOCFCapExFCFSBC
FY-4$2.29B-$266.3M$591.8M
FY-3$2.04B-$268.5M-$42.2M
FY-2$1.07B-$412.4M$280.5M
FY-1$692.7M-$670.9M-$229.5M
FY0$1.11B-$1.08B-$1.60B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7$1.25B$125.6M$88.8M-$2.7M
FQ-6$1.38B$187.8M$118.6M$19.1M
FQ-5$1.64B$410.2M$292.3M-$164.9M
FQ-4$1.37B$267.4M$151.4M-$72.5M
FQ-3$1.27B$368.8M$233.2M-$173.2M
FQ-2$1.26B$186.5M$109.1M-$490.7M
FQ-1$1.24B$57.7M-$5.1M-$861.4M
FQ0$1.24B$128.0M$37.5M-$60.9M
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7$7.16B$2.68B$1.54B
FQ-6$7.58B$2.76B$1.12B
FQ-5$7.11B$2.79B$837.4M
FQ-4$7.28B$2.65B$771.3M
FQ-3$7.54B$2.81B$1.13B
FQ-2$7.63B$2.47B$1.07B
FQ-1$7.23B$1.80B$502.2M
FQ0$7.46B$1.87B$652.9M
PeriodOCFCapExFCFSBC
FQ-7-$10.1M-$234.4M-$2.7M
FQ-6$264.4M-$412.9M$19.1M
FQ-5$692.7M-$670.9M-$164.9M
FQ-4$135.8M-$302.6M-$72.5M
FQ-3$657.4M-$539.9M-$173.2M
FQ-2$899.1M-$820.7M-$490.7M
FQ-1$1.11B-$1.08B-$861.4M
FQ0$299.2M-$167.3M-$60.9M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.68B
Net cash-$971.5M
Current ratio2.5
Debt/Equity0.9
ROA1.2%
ROE3.3%
Cash conversion-11.0%
CapEx/Revenue-18.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 4 companies
MetricUNIP6Activity
Op margin10.0%8.0% medp25 -2.2% · p75 23.4%above median
Net margin7.1%5.5% medp25 -3.8% · p75 18.5%above median
Gross margin23.2%20.5% medp25 12.4% · p75 29.7%above median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-18.7%8.6% medp25 1.7% · p75 15.7%bottom quartile
Debt / equity94.0%37.1% medp25 10.3% · p75 82.0%top quartile
Observations
IR observations
Mean price target64.00 BRL
Median price target64.00 BRL
High price target70.00 BRL
Low price target58.00 BRL
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate3.67 BRL
Last actual EPS4.10 BRL
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-16 01:09 UTC#b7ead8b7
Market quoteclose BRL 62.24 · shares 0.07B diluted
no public URL
2026-05-16 01:09 UTC#1dbcb258
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 20:54 UTCJob: 5c0ffbc3